J. Lamoureux et A. Castonguay, ABSENCE OF METABOLISM OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK) BY FLAVIN-CONTAINING MONOOXYGENASE (FMO), Carcinogenesis, 18(10), 1997, pp. 1979-1984
The N-nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
is a potent lung carcinogen present in tobacco and tobacco smoke, Car
bonyl reduction, alpha-carbon hydroxylation (activation) and N-oxidati
on of the pyridyl ring (detoxification) are the three main pathways of
metabolism of NNK, In this study, metabolism of NNK was studied with
lung and liver microsomes from F344 rats, Syrian golden hamsters and p
igs and cloned flavin-containing monooxygenases (FMOs) from human and
rabbit liver, Thermal inactivation at 45 degrees C for 2 min reduced F
MO S-oxygenating activity but did not affect N-oxidation of NNK, leadi
ng to the conclusion that FMOs are not implicated in the detoxificatio
n of NNK, Detoxification of NNK was not increased by n-octylamine or b
y incubation at pH 8.4, supporting the conclusion that FMOs are not in
volved in the metabolism of NNK, SKF-525A (1 mM) significantly reduced
N-oxidation and alpha-carbon hydroxylation, suggesting that these two
pathways were catalyzed by cytochromes P450, Metabolism of NNK was lo
wer with lung microsomes than with liver microsomes, Inhibition of met
abolism of NNK by SKF-525A was also observed with rat lung microsomes,
leading to the conclusion that cytochromes P450 are involved in pulmo
nary metabolism of NNK, Cloned FMOs did not metabolize NNK, In conclus
ion, cytochromes P450 rather than FMOs are involved in N-oxidation of
NNK, The high capacity of hamster liver microsomes to activate NNK doe
s not correlate with the resistance of this tissue to NNK-induced hepa
tocarcino-genesis.